GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Melodiol Global Health Ltd (OTCPK:COPHD) » Definitions » EV-to-FCF

Melodiol Global Health (Melodiol Global Health) EV-to-FCF : -1.06 (As of Jun. 21, 2024)


View and export this data going back to 2017. Start your Free Trial

What is Melodiol Global Health EV-to-FCF?

EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Melodiol Global Health's Enterprise Value is $6.03 Mil. Melodiol Global Health's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2023 was $-5.67 Mil. Therefore, Melodiol Global Health's EV-to-FCF for today is -1.06.

The historical rank and industry rank for Melodiol Global Health's EV-to-FCF or its related term are showing as below:

COPHD' s EV-to-FCF Range Over the Past 10 Years
Min: -15.46   Med: -2.52   Max: -0.28
Current: -1.07

During the past 8 years, the highest EV-to-FCF of Melodiol Global Health was -0.28. The lowest was -15.46. And the median was -2.52.

COPHD's EV-to-FCF is ranked worse than
100% of 535 companies
in the Drug Manufacturers industry
Industry Median: 22.83 vs COPHD: -1.07

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-06-21), Melodiol Global Health's stock price is $0.117. Melodiol Global Health's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was $-7.564. Therefore, Melodiol Global Health's PE Ratio for today is At Loss.


Melodiol Global Health EV-to-FCF Historical Data

The historical data trend for Melodiol Global Health's EV-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Melodiol Global Health EV-to-FCF Chart

Melodiol Global Health Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-FCF
Get a 7-Day Free Trial -1.61 -15.88 -4.09 -2.38 -2.18

Melodiol Global Health Semi-Annual Data
Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
EV-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -4.09 - -2.38 - -2.18

Competitive Comparison of Melodiol Global Health's EV-to-FCF

For the Drug Manufacturers - Specialty & Generic subindustry, Melodiol Global Health's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Melodiol Global Health's EV-to-FCF Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Melodiol Global Health's EV-to-FCF distribution charts can be found below:

* The bar in red indicates where Melodiol Global Health's EV-to-FCF falls into.



Melodiol Global Health EV-to-FCF Calculation

Melodiol Global Health's EV-to-FCF for today is calculated as:

EV-to-FCF=Enterprise Value (Today)/Free Cash Flow (TTM)
=6.029/-5.668
=-1.06

Melodiol Global Health's current Enterprise Value is $6.03 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Melodiol Global Health's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2023 was $-5.67 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Melodiol Global Health  (OTCPK:COPHD) EV-to-FCF Explanation

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Melodiol Global Health's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=0.117/-7.564
=At Loss

Melodiol Global Health's share price for today is $0.117.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Melodiol Global Health's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was $-7.564.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.


Melodiol Global Health EV-to-FCF Related Terms

Thank you for viewing the detailed overview of Melodiol Global Health's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Melodiol Global Health (Melodiol Global Health) Business Description

Traded in Other Exchanges
Address
145 Stirling Highway, Suite 5 CPC, Nedlands, WA, AUS, 6009
Melodiol Global Health Ltd is engaged in developing, registering, and commercialization of pharmaceutical-grade cannabis and hemp-based nutraceutical products and treatments for human and animal health. Its brands include Mernova: A licensed producer of cannabis products in Canada for sale under the Ritual brand banner. Sierra Sage Herbs: US-based developer of plant-based, beauty, and personal care brands Green Goo, Southern Butter, and Good Goo. impACTIVE: CBD topical products for athletes. Halucenex: Clinical stage psychedelics research and development operation. Creso Pharma Switzerland: CBD-related research, development, and commercialization.

Melodiol Global Health (Melodiol Global Health) Headlines

From GuruFocus

Sierra Sage Herbs Acquired By Creso Pharma

By PRNewswire PRNewswire 02-07-2022